Previous close | 17.79 |
Open | 17.89 |
Bid | 17.87 x 1400 |
Ask | 17.88 x 900 |
Day's range | 17.43 - 17.92 |
52-week range | 10.84 - 24.79 |
Volume | |
Avg. volume | 2,401,675 |
Market cap | 4.559B |
Beta (5Y monthly) | 0.79 |
PE ratio (TTM) | 4.47 |
EPS (TTM) | 3.99 |
Earnings date | 02 May 2024 |
Forward dividend & yield | 1.12 (6.30%) |
Ex-dividend date | 23 Feb 2024 |
1y target est | 21.50 |
JERSEY CITY, N.J., April 08, 2024--Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024
SHANGHAI, China & JERSEY CITY, N.J., April 08, 2024--Organon and Henlius announce that Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoint
JERSEY CITY, N.J., February 20, 2024--Organon Announces HADLIMA Has Been Exclusively Selected by the US Department of Veterans Affairs (VA), Replacing HUMIRA on Its National Formulary